Comparing the Use of a Mobile App and a Web-Based Notification Platform for Surveillance of Adverse Events Following Influenza Immunization: Randomized Controlled Trial
JMIR Public Health and Surveillance · 2023
DOI: 10.2196/39700 ↗At a glance
Randomisierte kontrollierte Studie in JMIR Public Health and Surveillance, 2023. Written by A Brianne Bota and 11 co-authors. Institution: Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada. Major MEDLINE topics: Mobile Applications, Influenza, Human, COVID-19, Influenza Vaccines. Cited 4 times so far (Crossref); 23 references. The full text is freely available in PubMed Central. Funded by: CIHR.
Topics: Patientensicherheit
Abstract (original language)
Background
Vaccine safety surveillance is a core component of vaccine pharmacovigilance. In Canada, active, participant-centered vaccine surveillance is available for influenza vaccines and has been used for COVID-19 vaccines.
Objective
The objective of this study is to evaluate the effectiveness and feasibility of using a mobile app for reporting participant-centered seasonal influenza adverse events following immunization (AEFIs) compared to a web-based notification system.
Methods
Participants were randomized to influenza vaccine safety reporting via a mobile app or a web-based notification platform. All participants were invited to complete a user experience survey.
Results
Among the 2408 randomized participants, 1319 (54%) completed their safety survey 1 week after vaccination, with a higher completion rate among the web-based notification platform users (767/1196, 64%) than among mobile app users (552/1212, 45%; P
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
- Vaccine Evaluation Center, BC Children's Hospital Research Institute, Vancouver, BC, Canada.
- Karolinska Institutet, Solna, Sweden.
- CanImmunize Inc, Ottawa, ON, Canada.
- Department of Social and Behavioral Sciences, Yale School of Public Health, New Haven, CT, United States.
- Department of Medicine, University of Ottawa, Ottawa, ON, Canada.
ORCID profiles: A Brianne Bota, Julie A Bettinger, Shirley Sarfo-Mensah, Jimmy Lopez, David P Smith, Katherine M Atkinson, Cameron Bell, Kim Marty, Mohamed Serhan, David T Zhu, Anne E McCarthy, Kumanan Wilson
Funding
- CIHR
Cite
APA
Bota, A. B., Bettinger, J. A., Sarfo-Mensah, S., Lopez, J., Smith, D. P., Atkinson, K. M., Bell, C., Marty, K., Serhan, M., Zhu, D. T., McCarthy, A. E., & Wilson, K. (2023). Comparing the Use of a Mobile App and a Web-Based Notification Platform for Surveillance of Adverse Events Following Influenza Immunization: Randomized Controlled Trial. JMIR Public Health and Surveillance. https://doi.org/10.2196/39700
Vancouver
Bota AB, Bettinger JA, Sarfo-Mensah S, Lopez J, Smith DP, Atkinson KM, et al. Comparing the Use of a Mobile App and a Web-Based Notification Platform for Surveillance of Adverse Events Following Influenza Immunization: Randomized Controlled Trial. JMIR Public Health and Surveillance. 2023. doi:10.2196/39700
BibTeX
@article{Bota2023,
author = {Bota, A Brianne and Bettinger, Julie A and Sarfo-Mensah, Shirley and Lopez, Jimmy and Smith, David P and Atkinson, Katherine M and Bell, Cameron and Marty, Kim and Serhan, Mohamed and Zhu, David T and McCarthy, Anne E and Wilson, Kumanan},
title = {Comparing the Use of a Mobile App and a Web-Based Notification Platform for Surveillance of Adverse Events Following Influenza Immunization: Randomized Controlled Trial},
journal = {JMIR Public Health and Surveillance},
year = {2023},
doi = {10.2196/39700}
}
EUVIMED